“When it comes to getting aid right, an all-too-familiar problem seems to be balancing the priorities of rich governments with what communities actually want,” AlertNet reports in an article examining an essay written by Oxford University researcher Devi Sridhar and published in PLOS Medicine. The essay “assesses the system of financing for health research,” according to the news service (Nguyen, 9/26). “Sridhar argues that since the priorities of funding bodies largely dictate what health issues and diseases are studied, a major challenge in the governance of global health research funding is agenda-setting, which in turn is a consequence of a larger phenomenon — ‘multi-bi financing,'” according to a PLOS press release (9/25). “Multi-bi financing refers to the practice of donors choosing to route non-core funding — earmarked for specific sectors, themes, countries, or regions — through multilateral agencies such as the World Health Organization (WHO) and the World Bank and to the emergence of new multi-stakeholder initiatives such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance,” she writes.
“During these tough budget times, citizens across the world rightfully question the effectiveness of government spending, including funds spent on foreign assistance,” Daniel Yohannes, chief executive officer of the Millennium Challenge Corporation (MCC), writes in this Foreign Policy opinion piece. “At the Millennium Challenge Corporation, an independent U.S. foreign aid agency with a global investment portfolio of more than $9.3 billion, we believe our assistance should be earned,” he writes. “MCC is an integral part of the administration’s comprehensive efforts to modernize U.S. development policies and programs, placing us at the forefront of foreign aid reform,” he continues, adding, “And one of the most effective tools we have to carry out this mission is the ability to say ‘no.'”
“India has had a positive global impact through its supply of vast quantities of low-cost, good-quality generic medicines, which have saved or prolonged millions of lives … [b]ut there are also many factors that may hinder the continuation of the [country's] role as chief supplier of medicines to developing countries,” Martin Khor, executive director of the South Centre in Geneva, writes in an Inter Press Service opinion piece. He examines the history of generic drug production in India and says the 1995 World Trade Organization TRIPS agreement negatively affected the country’s ability to produce generic drugs. Though “India has one of the best patent laws in the world that still gives some space to its producers to make generic drugs, … it is also true that the old policy space has been eroded because many new drugs have, since 2005, been patented by multinational companies that are selling them at exorbitant prices,” Khor writes.
In a post on the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, foundation Co-Chair Bill Gates writes about traveling to New York this week to deliver a speech to the U.N. on polio eradication, one of the top five global health priorities as described by U.N. Secretary-General Ban Ki-moon. “New polio cases are the lowest they’ve ever been and there are currently just three countries, down from 125 in 1988, where polio is still endemic: Afghanistan, Nigeria, and Pakistan,” Gates notes. He adds, “[T]he world is coming together with the financial resources, the political commitment, and the innovation necessary to do something absolutely extraordinary, to protect every child everywhere from this preventable disease” (9/25).
Following the XIX International AIDS Conference (AIDS 2012) in July, “delegates left Washington with a clear focus on achieving an AIDS-free generation,” Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, writes in the Huffington Post’s “The Big Push” blog. “But in the weeks following, HIV/AIDS and global health have largely disappeared from our political dialogue,” he says, because “[n]ational attention is squarely focused on the November elections, and we haven’t seen the ‘post-conference’ bounce that these issues deserve.” He continues, “Although there was mention of support for PEPFAR and the Global Fund [to Fight AIDS, Tuberculosis and Malaria] at this summer’s conventions, this kind of high-level call to action was noticeably absent in Tampa and Charlotte.”
Noting successes achieved under the Every Woman Every Child campaign and the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, UNAIDS Executive Director Michel Sidibe writes in the Huffington Post’s “The Big Push” blog that leaders “have stepped up and stood strong for critical issues on the women’s and children’s health agenda to advance the health Millennium Development Goals and ensure the sustainability of results beyond 2015.” He adds, “Most of all, they have engaged in a radical paradigm shift that places the notion of global solidarity at the core of our work.” With the estimated number of children newly infected with HIV dropping and more women undergoing HIV testing and receiving antiretroviral medications, “[t]hese achievements deserve global attention,” Sidibe says.
“No woman should die giving birth, and yet maternal mortality, despite progress, remains one of the leading causes of death among women of reproductive age in developing countries,” Mary Ellen Stanton, senior maternal health adviser for the Global Health Bureau, writes in USAID’s “IMPACTblog.” She notes, “Most of these deaths are preventable.” She highlights the Saving Mothers, Giving Life initiative, writing it “represents a unique partnership through which the United States government has enlisted significant support from key public, private and non-governmental players in the global health field with one collective purpose — to reduce maternal mortality” (9/24).
“This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon’s ‘Every Woman, Every Child’ dinner in New York,” an event that “will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries,” Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post’s “The Big Push” blog. “Ten years ago, tackling HIV, tuberculosis [TB] and malaria seemed an almost impossible task. Today we can see the beginning of the end of these three killer diseases,” she continues, adding, “But to make these historic achievements possible we need sufficient resources available!”
“[W]hat will the day be like when we finally defeat AIDS, tuberculosis and malaria?” Arianna Huffington, president and editor-in-chief of the Huffington Post Media Group, asks in the Huffington Post’s “The Big Push” blog. “[W]ith the launch today of The Big Push campaign — co-sponsored by the Global Fund [to Fight AIDS, Tuberculosis and Malaria] and the Huffington Post — this might be more than a thought exercise … because the progress that’s been made against these diseases in only the last 10 years has been so staggering that we may actually be in sight of the day when no child is born with HIV, nobody dies of malaria and we stop the spread of tuberculosis,” she continues and provides some statistics.
In this post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Gary Darmstadt, head of the family health division of the foundation, family planning expert Monica Kerrigan, and Wendy Prosser, a research analyst with the foundation’s family health division, examine global initiatives “launched in recent months and years” that bring “needed attention to women’s and children’s health,” including “the Muskoka Initiative, Every Woman Every Child, the Child Survival Promise to Keep, and the Millennium Development Goals.” They highlight the goals and metrics established at the Summit on Family Planning in July and write, “We hope this is not just another commitment that generates a lot of attention and then fades away” (9/21).